|
|
|
|
|
|
| Advertisement |
FDA expedited programs can reduce drug development timelines by months. Learn how products qualify and steps to successfully accelerate product approval.
 Read more
|
|
| Regulatory Affairs |
 |
|
Bracing for Drug Tracing Mandate
|
Pilot study affirms the value of a standards-based solution for prescription drug traceability—and the need to start now to meet compliance deadlines for the Drug Supply Chain Security Act.
... /Read more/ |
|
|
| Advertisement |
5 Benefits of Liquidating Your Sales Fleet
Providing fleet vehicles to your sales reps seems like a great idea on the surface, but in fact there are many issues hiding below. Have you considered how much a fleet is costing your organization? Reimbursement is an alternative that not only pays off for you but also for your sales reps. Discover the five benefits of transitioning from a fleet program to vehicle reimbursement.
 Read more
|
|
| Regulatory Affairs |
|
|
The EFPIA Disclosure Experience: An Update
|
Nine months on from the 2016 EFPIA Disclosure Code deadline — requiring all member companies to publish data concerning their transfer-of-value transactions to HCPs — EFPIA's Andrew Powrie-Smith offered an update on media and industry responses.
... /Read more/ |
|
|
|
| Calendar |
|
| Advertisement |
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
Live Webinar: Tuesday, May 2 at 11:00am EDT
 Register now
|
|
 |
|
|
| Advertisement |
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT
 Register now
|
|
|
|
|
|
|
|
